FINRA suspends Vfinance broker Jeffrey Auerbach

In September, 2015, the Financial Industry Regulatory Authority (“FINRA”) announced that Jeffrey Auerbach of New York, NY, and formerly associated with Vfinance Investments submitted a letter of Acceptance, Waiver and Consent in which he was fined $15,000 and suspended from association with any FINRA member inany capacity for 90 days.

Without admitting or denying the findings, Jeffrey Auerbach consented to the sanctions and to the entry of findings that he participated in private securities transactions totaling $218,000 without first seeking and receiving his member firm’s written approval. The findings stated that Auerbach attested on compliance questionnaires that he did not participate in any private securities transactions outside of the firm. The suspension is in effect from July 20, 2015, through October 17, 2015.

 Jeffrey Auerbach’s registration and disciplinary history

In order to lawfully sell investments to the public, one must either be registered or exempt from registration.

Jeffrey Auerbach was registered with:

04/2013 – 11/2013
01/2013 – 04/2013
 03/2012 – 12/2012
04/2003 – 12/2012
12/2001 – 04/2003

According to FINRA’s CRD disclosure report, Jeffrey Auerbach has been the subject of four customer complaints and fourteen regulatory investigations.

The Law Office of David Liebrader practices exclusively in the field of investment loss recovery. For the past 23 years, we have dedicated our law practice to assisting investors who have been victims of investment fraud via fraudulent and unsuitable investment transactions. During that time we have recovered money for over one thousand individuals, pension plans, trusts and companies. The recoveries we have obtained via judgments, awards and settlements on behalf of our clients exceed $40,000,000.

When investors contact our firm they can expect prompt attention, and a detailed analysis of their issues. Typical claims that we are asked to review involve “unsuitability (where a financial advisor makes investment recommendations that are inconsistent with a customer’s investment objectives), claims for “churning” (where a broker enters into an excessive number of trades for the purpose of generating commissions), claims involving illiquid investments such as private placements (I.e., real estate investment trusts, limited partnerships, equipment leasing and oil and gas drilling programs) as well as claims for violations of state securities laws, which often provide investors remedies like attorney’s fees and interest, if they are successful on the claim.

Since a Supreme Court ruling in the 1980s, most investment related disputes between brokerage firms and their customers have been filed in an arbitration forum hosted by FINRA Dispute Resolution. FINRA, along with the SEC, serves as a securities industry “watchdog” and regulator. Most brokerage firms require their clients to sign binding arbitration agreements, mandating that any disputes between them be arbitrated at FINRA.

Investors pursuing claims at FINRA typically advance claims related to suitability. FINRA rules require that all registered representatives make suitable investment recommendations to their clients. Other claims are based on negligence or breach of fiduciary duty, while another category includes claims based on misrepresentations and fraud. Most claims filed with FINRA are resolved within 15 months, and oftentimes, the cases are resolved via settlement or mediation in under a year.

FINRA’s rules require that all investment recommendations made by licensed financial advisors be suitable in light of a customer’s needs, objectives and risk tolerance. In addition, all registered representatives are required to be properly supervised, with periodic inspections and reviews by qualified supervisors, whose job it is to vigorously investigate suspicions of wrongdoing (red flags).

If you suspect that you have been the victim of investment fraud, or had a financial advisor recommend unsuitable investments to you, call us today for a free, confidential consultation at (702) 380-3131.



Contact Information